+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Stem Cell Banking - Global Market Trajectory & Analytics

  • ID: 4911777
  • Report
  • February 2022
  • Region: Global
  • 289 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Cord Blood Registry
  • CordLife Group Ltd.
  • Cryo-Save AG
  • StemCyte Inc.
  • ViaCord
  • Vita 34 AG

Global Stem Cell Banking Market to Reach $11.3 Billion by 2027


Amid the COVID-19 crisis, the global market for Stem Cell Banking estimated at US$6.8 Billion in the year 2020, is projected to reach a revised size of US$11.3 Billion by 2027, growing at a CAGR of 7.5% over the analysis period 2020-2027. Placental and Cord Blood Stem Cells, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$7.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the ADipose Tissue-derived Stem Cells (adscs) segment is readjusted to a revised 6.9% CAGR for the next 7-year period.



The U.S. Market is Estimated at $2.9 Billion, While China is Forecast to Grow at 10% CAGR


The Stem Cell Banking market in the U.S. is estimated at US$2.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 10% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Bone Marrow-Derived Stem Cells (BMSCS) Segment to Record 5.5% CAGR


In the global Bone Marrow-Derived Stem Cells (BMSCS) segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$580.5 Million in the year 2020 will reach a projected size of US$838.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$954.5 Million by the year 2027.

Select Competitors (Total 78 Featured) -

  • Cord Blood Registry
  • CordLife Group Ltd.
  • Cryo-Cell International, Inc.
  • Cryo-Save AG
  • Global Cord Blood Corporation
  • LifeCell International Pvt., Ltd.
  • Smart Cells International Ltd.
  • StemCyte Inc.
  • ViaCord
  • Vita 34 AG
Frequently Asked Questions about the Global Market for Stem Cell Banking

What is the estimated value of the Global Market for Stem Cell Banking?

The Global Market for Stem Cell Banking was estimated to be valued at $6.8 Billion in 2020.

What is the growth rate of the Global Market for Stem Cell Banking?

The growth rate of the Global Market for Stem Cell Banking is 7.5%, with an estimated value of $11.3 Billion by 2027.

What is the forecasted size of the Global Market for Stem Cell Banking?

The Global Market for Stem Cell Banking is estimated to be worth $11.3 Billion by 2027.

Who are the key companies in the Global Market for Stem Cell Banking?

Key companies in the Global Market for Stem Cell Banking include Cord Blood Registry, CordLife Group Ltd., Cryo, Cell International, Inc., Cryo, Save AG, Global Cord Blood Corporation, LifeCell International Pvt., Ltd. and StemCyte Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cord Blood Registry
  • CordLife Group Ltd.
  • Cryo-Save AG
  • StemCyte Inc.
  • ViaCord
  • Vita 34 AG

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Stem Cells, Application Areas, and the Different Types - A Prelude
  • Applications of Stem Cells
  • Types of Stem Cells
  • Cord Blood
  • Umbilical Cord Tissue
  • Bone Marrow Stem Cells
  • Adipose-Derived Stem Cells (ADSCs)
  • Number of Clinical Trials Using Adipose Stem Cells: 2007-2018
  • Number of Adipose Stem Cell Trials by Phase: 2007 to 2018
  • Human Embryo-Derived Stem Cells (HESCS)
  • Global Stem Cell Banking Market Poised for a Rapid Growth
  • Developed Regions Lead, Emerging Economies to Spearhead Future Growth
  • List of Family Cord Blood Banks in the US
  • Placental and Cord Blood Banks Dominate the Cord Blood Banking Market
  • Global Number of Annual Newborns and Private Cord Blood Banks
  • Global Select Leading Cord Blood Banks Based on Inventory
  • A Peek into China’s Cord Blood Banking Industry
  • Evolving Landscape of Cord Blood Banking Industry
  • Placental Stem Cells and Potential Clinical Applications
  • Global Cord Blood Banking Market Share Breakdown (%) by Bank Type: 2019
  • US Cord Blood Banking Market by Bank Type (in %) for 2019
  • Changing Business Models for Stem Cell Banking
  • Stem Cell Banking – Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Increasing Investments in Stem Cell-Based Research Widen Prospects for Stem Cell Banking Market
  • Stem Cell Research Funding in the US (in US$ Million) for the Years 2011 through 2017
  • Stem Cell Research Policies Impact Funding Volumes
  • Adult Stem Cell Research Gains Traction, Accelerating Research Funding
  • Adult Stem Cells Vs. Embryonic Stem Cells: A Comparison
  • Embryonic Stem Cell Research Bogged Down by Ethical Issues & Technical Hurdles
  • Induced Pluripotent Stem Cell (iPSC) Research: The Latest Vertical
  • Sustained Emphasis on Mesenchymal Stem Cell Research
  • Emergence of Advanced Technologies for Stem Cell Preservation, Storage and Processing Augurs Well for Market Growth
  • Growing Incidence of Major Diseases to Boost the Demand for Stem Cells, Driving Stem Cell Banking
  • Worldwide Incidence of Cancer (2012, 2018 & 2040): Number of New Cases Diagnosed
  • World Cancer Incidence by Cancer Type (2018): Number of New Cancer Cases Reported (in Thousands) for Breast, Cervix uteri, Colorectum, Liver, Lung, Oesophagus, Prostate, Stomach and Others
  • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
  • Ageing Demographics to Drive Demand for Stem Cell Banking
  • Global Aging Population Statistics – Opportunity Indicators
  • Elderly Population (60+ Years) as a Percentage of Total Population (2017 & 2050)
  • Global Aging Population (2017 & 2050): Population of 60+ Individuals in ‘000s and as a Percentage of Total Population
  • Life Expectancy for Select Countries in Number of Years: 2018
  • Bone Marrow Stem Cells Market on a Rapid Growth Path, Spurring the Need for Stem Cell Banking
  • Development of Regenerative Medicine Accelerates Demand for Mesenchymal Stem Cell Banking
  • Global Regenerative Medicines Market by Category (2019): Percentage Breakdown for Biomaterials, Stem Cell Therapies and Tissue Engineering
  • Rise in Volume of Orthopedic Procedures Boosts Prospects for Stem Cell Banking
  • Global Orthopedic Surgical Procedure Volume (2010-2020) (in Million)
  • Increasing Demand for Stem Cell Based Bone Grafts: Promising Growth Ahead for Stem Cell Banking
  • Rise in the Number of Hematopoietic Stem Cell Transplantation Procedures Propels Market Expansion
  • Hematopoietic Stem Cell Storage
  • Dental Mesenchymal Stem Cells: An Evolving Niche
  • Therapeutic Potential of Dental Pulp Stem Cells (DPSCs) in Various Diseases
  • High Operational Costs of Stem Cell Banking - A Key Market Restraint

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Stem Cell Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

  • Stem Cell Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

  • Stem Cell Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

  • Stem Cell Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

  • Stem Cell Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Stem Cell Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Stem Cell Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

REST OF EUROPE

ASIA-PACIFIC

  • Stem Cell Banking Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

REST OF WORLD

IV. COMPETITION

  • Total Companies Profiled: 78
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Cord Blood Registry
  • CordLife Group Ltd.
  • Cryo-Cell International, Inc.
  • Cryo-Save AG
  • Global Cord Blood Corporation
  • LifeCell International Pvt., Ltd.
  • Smart Cells International Ltd.
  • StemCyte Inc.
  • ViaCord
  • Vita 34 AG
Note: Product cover images may vary from those shown